GENEVA, Aug. 5 -- CURSUS BIO INC. (7F, 10 Bongeunsa-ro 104-gil,Gangnam-guSeoul 04763), 커서스바이오 주식회사 (서울특별시강남구봉은사로104길 10, 7층), IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (222, Wangsimni-roSeongdong-guSeoul 04736), 한양대학교 산학협력단 (서울특별시성동구왕십리로 222) filed a patent application (PCT/KR2025/001518) for "GENE DELIVERY PLATFORM FOR MULTI-ORGAN SEQUENTIAL TARGETING ORAL ADMINISTRATION" on Jan 24, 2025. With...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.